Bio-Works Technologies AB Statistics

Total Valuation

NGM:BIOWKS has a market cap or net worth of SEK 139.36 million. The enterprise value is 109.64 million.

Market Cap	139.36M
Enterprise Value	109.64M

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

NGM:BIOWKS has 78.73 million shares outstanding. The number of shares has increased by 61.11% in one year.

Current Share Class	78.73M
Shares Outstanding	78.73M
Shares Change (YoY)	+61.11%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	24.11%
Owned by Institutions (%)	12.81%
Float	39.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.25
PB Ratio	3.82
P/TBV Ratio	3.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.27
EV / Sales	3.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.80

Current Ratio	2.80
Quick Ratio	1.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-110.33

Financial Efficiency

Return on equity (ROE) is -83.18% and return on invested capital (ROIC) is -48.82%.

Return on Equity (ROE)	-83.18%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-48.82%
Return on Capital Employed (ROCE)	-86.21%
Revenue Per Employee	1.13M
Profits Per Employee	-1.15M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NGM:BIOWKS has paid 41,000 in taxes.

Income Tax	41,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.80% in the last 52 weeks. The beta is 1.09, so NGM:BIOWKS's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-32.80%
50-Day Moving Average	1.44
200-Day Moving Average	1.17
Relative Strength Index (RSI)	61.44
Average Volume (20 Days)	115,325

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:BIOWKS had revenue of SEK 32.82 million and -33.48 million in losses. Loss per share was -0.56.

Revenue	32.82M
Gross Profit	27.22M
Operating Income	-31.44M
Pretax Income	-33.44M
Net Income	-33.48M
EBITDA	-30.94M
EBIT	-31.44M
Loss Per Share	-0.56

Full Income Statement

Balance Sheet

The company has 29.72 million in cash and n/a in debt, giving a net cash position of 29.72 million or 0.38 per share.

Cash & Cash Equivalents	29.72M
Total Debt	n/a
Net Cash	29.72M
Net Cash Per Share	0.38
Equity (Book Value)	36.47M
Book Value Per Share	0.47
Working Capital	34.78M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-35.27M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 82.93%, with operating and profit margins of -95.81% and -102.02%.

Gross Margin	82.93%
Operating Margin	-95.81%
Pretax Margin	-101.90%
Profit Margin	-102.02%
EBITDA Margin	-94.27%
EBIT Margin	-95.81%
FCF Margin	n/a

Dividends & Yields

NGM:BIOWKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.11%
Shareholder Yield	-61.11%
Earnings Yield	-24.03%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:BIOWKS has an Altman Z-Score of -6.78 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.78
Piotroski F-Score	1